Custom Antibody Services Market Size, Growth, Share by 2031
定制抗体服务市场规模预计将从 2023 年的 5.9033 亿美元增至 2031 年的 12.1635 亿美元。预计该市场在 2023-2031 年的复合年增长率为 9.5%。利用重组抗体的技术进步可能会在未来几年为定制抗体服务市场带来新趋势。
定制抗体服务市场分析
推动定制抗体服务市场发展的因素包括政府对抗体相关领域研究的资助和支持,以及向转化医学的扩展。对个性化医疗的日益重视推动了对定制抗体解决方案的需求。重组抗体的技术进步正在推动定制抗体服务市场的增长。对定制诊断和治疗的需求不断增长,促使参与者投资于产品开发和扩张战略。
定制抗体服务市场概况
定制抗体对于个性化治疗至关重要,因为它们可以设计为针对特定患者疾病特有的特定分子标记。由于癌症和心血管疾病等慢性病的患病率不断上升,英国的定制抗体服务市场预计将大幅增长。据英国癌症研究中心称,英国每年约有 360,000 人被诊断出患有癌症。到 2040 年,每年的癌症诊断数量预计将达到 500,000。事实证明,抗体可以延长总体无病生存期,并在某些情况下延缓疾病进展。需要定制抗体服务来开发更有针对性的治疗性抗体疗法,以更有效地治疗癌症。
定制抗体可以帮助靶向特定的肿瘤标志物,提高癌症治疗的有效性并减少副作用。2023 年 9 月,AMSBIO 向德国多特蒙德工业大学的研究人员提供了一种定制的单克隆抗体,以揭示 EDI3(一种参与胆碱代谢的甘油磷酸二酯酶)在乳腺癌发展中的作用、HER2 信号对其的调节以及其作为治疗靶点的潜力。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
定制抗体服务市场:
复合年增长率(2023 - 2031)9.5%- 2023 年市场规模
5.9033 亿美元 - 市场规模 2031
12.1635 亿美元
市场动态
- 慢性病患病率上升
- 生物仿制药获批数量不断增加Biosimilars
- 政府研发活动的增加
关键人物
- 赛默飞世尔科技公司 Fisher Scientific Inc
- 中国义翘神州生物公司 Biological Inc
- 金斯瑞生物科技股份有限公司 Biotech Corporation
- Biochain 公司 Incorporated
- RD 系统公司
- 钟渊欧洲技术公司 Eurogentec S A
- 富通生命科学 Life Sciences
- 精准抗体
- 百奥赛图生物技术北京有限公司
- 艾比尼克斯
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 单克隆
- 多克隆杂交瘤
- 重组抗体
- 抗体发现与开发
- 抗体生产服务
- 免疫组织化学
- 蛋白质印迹法和免疫沉淀法
- 酶联免疫吸附试验
- 荧光激活细胞分选
- 质谱分析
- 肿瘤学
- 传染病
- 免疫学
- 心血管疾病
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
定制抗体服务市场驱动因素和机遇
生物仿制药获批数量增加有利于市场增长
美国食品药品管理局 (FDA) 批准生物仿制药,并提供将安全有效的生物仿制药推向市场所需的科学和监管建议。生物仿制药的批准可以增加药物选择的数量,同时降低成本,从而改善患者护理。
以下是一些最近批准的生物仿制药产品:
生物仿制药名称 | 批准日期 | 参考产品 |
Alymsys(贝伐单抗) | 2022 年 4 月 | 阿瓦斯汀(贝伐单抗) |
Cimerli(雷珠单抗-eqrn) | 2022 年 8 月 | Lucentis(雷珠单抗) |
Fylnetra(聚乙二醇非格司亭-pbbk) | 2022 年 5 月 | Neulasta(培非格司亭) |
Stimufend(聚乙二醇非格司亭-fpgk) | 2022 年 9 月 | Neulasta(培非格司亭) |
Vegzelma(贝伐单抗-adcd) | 2022 年 9 月 | 阿瓦斯汀(贝伐单抗) |
Idacio(阿达木单抗-aacf) | 2022 年 12 月 | Humira(阿达木单抗) |
生物仿制药可以降低治疗成本并改善患者获得生物疗法的机会。近年来,FDA 批准了大量生物仿制药。据 ScienceDirect.com 称,生物仿制药可以保持成本并扩大单克隆抗体的可用性。此外,在欧洲,有五种利妥昔单抗生物仿制药、六种曲妥珠单抗生物仿制药和八种贝伐单抗生物仿制药可用作抗癌药物。因此,生物仿制药的批准不断增加推动了定制抗体服务市场的增长。
新兴和发达经济体政府研发活动增加
各个新兴国家的政府正在启动多项以基因组学和蛋白质组学方法为重点的研究和开发计划。例如,印度的蛋白质组学学会旨在促进蛋白质组学领域和该国蛋白质组学界的专业兴趣。该组织还帮助促进研究合作和研讨会,推动对定制抗体产品的需求。美国的单细胞蛋白质组学计划于 2022 年由精通执行单细胞蛋白质组学 (SCP) 工作流程的国际实验室成立。2022 年公布的生物学和疾病驱动的人类蛋白质组项目下的单细胞计划的目标促进了 SCP 方法和技术的开发和应用。该计划旨在加速成熟和新感兴趣的 SCP 研究人员之间的知识交流和资源。该计划组织网络研讨会、研讨会和座谈会,展示 SCP 的现代进步和挑战,并通过生成专用资源进行补充。因此,预计各发展中经济体政府加大研发力度将为预测期内定制抗体服务市场的增长创造丰厚的机会。
定制抗体服务市场报告细分分析
有助于得出定制抗体服务市场分析的关键部分是产品类型、服务类型、应用、来源、疾病指征和最终用户。
- 根据产品类型,定制抗体服务市场分为单克隆抗体、多克隆杂交瘤抗体、重组抗体等。单克隆抗体在 2023 年占据了最大的市场份额。
- 根据服务类型,定制抗体服务市场分为抗体发现和开发、抗体生产服务和其他。抗体发现和开发部分在 2023 年占据了最大的市场份额。
- 根据应用,市场分为免疫组织化学、蛋白质印迹和 IP、ELISA、荧光激活细胞分选、质谱等。ELISA 领域在 2023 年占据了市场主导地位。
- 就疾病适应症而言,定制抗体服务市场细分为肿瘤学、传染病、免疫学、心血管疾病等。2023 年,肿瘤学领域占据了市场主导地位。
- 根据来源,定制抗体服务市场分为鸡、兔、大鼠、豚鼠、小鼠或人源化小鼠等。小鼠或人源化小鼠部分在 2023 年占据了最大的市场份额。
- 就最终用户而言,定制抗体服务市场细分为生命科学行业、制药和生物技术公司、学术和研究机构以及合同研究组织。生命科学行业在 2023 年占据了最大的市场份额。
定制抗体服务市场份额分析(按地区)
定制抗体服务市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
2023 年,北美占据了相当大的市场份额。市场的增长得益于政府机构和市场参与者之间日益加强的合作,以鼓励在临床诊断中使用定制抗体。此外,先进技术解决方案的接受和采用、药物发现和开发投资的增加、政府对临床研究的广泛支持以及临床诊断研究活动的激增预计将加速该地区定制抗体服务市场的增长。
美国和加拿大大学开展的癌症和基因组研究项目数量不断增加、对开发抗体疗法的日益关注、大量全球参与者的存在以及对高质量数据可重复性研究工具的需求不断增长,这些都是促使北美市场扩张的其他一些因素。
定制抗体服务市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 5.9033亿美元 |
2031 年市场规模 | 12.1635亿美元 |
全球复合年增长率(2023 - 2031) | 9.5% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
定制抗体服务市场新闻和最新发展
定制抗体服务市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。定制抗体服务市场的一些发展如下所列:
- 义翘神州生物科技公司在美国德克萨斯州休斯顿的 Levit Green 开设了新的生物加工中心 (C4B),毗邻世界著名的德克萨斯医学中心。新中心被称为 C4B,专门提供合同研究服务,包括定制重组蛋白和重组抗体的开发和制造。新中心专注于利用哺乳动物细胞开发和生产研究级和诊断级蛋白质和抗体,这些细胞拥有独特的机制,可以产生具有高生物活性的天然、体内类似产品。(来源:义翘神州生物科技公司,新闻稿,2023 年 10 月)
- Fortis Life Sciences 收购了优质抗体公司 Bethyl Laboratories。Bethyl Laboratories 总部位于德克萨斯州,长期以来一直为客户提供最高质量的一抗和二抗以及其他蛋白质检测试剂。(来源:Fortis Life Sciences,新闻稿,2021 年 3 月)
定制抗体服务市场报告覆盖范围和交付成果
“定制抗体服务市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:
- 定制抗体服务市场规模及全球、区域和国家层面所有主要细分市场的预测
- 定制抗体服务市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST 和 SWOT 分析
- 定制抗体服务市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及定制抗体服务市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Custom antibodies are essential to personalized therapies, as they can be designed to target specific molecular markers that are unique to an individual patient's disease. Custom antibody services are specialized services provided by companies to develop antibodies tailored to specific needs for research, diagnostic, and therapeutic purposes. These services include the entire process, from antigen design, immunization, and antibody production to purification and validation.
The factors driving the growth of the custom antibody services market include the increasing prevalence of chronic diseases and rising approvals of biosimilars. However, the high costs and complexities associated with antibody production using transgenic animals hampers the growth of the custom antibody services market.
The custom antibody services market majorly consists of the players, including Thermo Fisher Scientific Inc.; Sino Biological Inc.; GenScript Biotech Corporation; Biochain Incorporated; R&D Systems, Inc.; Kaneka Eurogentec S.A.; Fortis Life Sciences; Precision Antibody; Biocytogen Pharmaceuticals Beijing Co Ltd; and Abgenex.
The custom antibody services market was valued at US$ 590.33 million in 2023.
The custom antibody services market is expected to be valued at US$ 1,216.35 million by 2031.
The custom antibody services market, by product type, is segmented into monoclonal, polyclonal hybridoma, recombinant antibody, and others. In 2023, the monoclonal segment held the largest share of the market.
The List of Companies - Custom Antibody Services Market
- Thermo Fisher Scientific Inc.
- Sino Biological Inc.
- GenScript Biotech Corporation
- Biochain Incorporated
- R&D Systems, Inc.
- Kaneka Eurogentec S.A.
- Fortis Life Sciences
- Precision Antibody
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Abgenex.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.